Pylarify

Active Awarded Last action

Contract number
36C24125F0139
Awardee
Awarding agency
Obligated
$1,342,444

Award facts

Contract value 100% obligated
$1,342,443.84 Current and potential, with all options
Completion date 92% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Jamaica Plain, MA 02130, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 $187,653
Original award $1,154,790

About this award

Veterans Integrated Service Network 1 issued a $1.34 million delivery order to Progenics Pharmaceuticals Inc. on July 21, 2025, for supply of PYLARIFY (piflufolastat F-18), a radiopharmaceutical diagnostic imaging agent for positron emission tomography scans, under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).

The Pharmaceuticals and Drugs FSS is a General Services Administration schedule contract that enables federal healthcare providers to procure diagnostic and pharmaceutical products through firm fixed-price delivery orders. Place of performance is Jamaica Plain, MA 02130. The order has a ceiling value of $1.34 million with an ultimate completion date of November 30, 2026. Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc., is the sole authorized manufacturer of PYLARIFY and supplies the product to the Department of Veterans Affairs and other federal healthcare providers. This order carries no set-aside designation.

Quick answers

Who was awarded contract 36C24125F0139?

36C24125F0139 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 1 (Veterans Health Administration) on July 21, 2025.

How much is contract 36C24125F0139 worth?

The government has obligated $1,342,444 on 36C24125F0139.

Is contract 36C24125F0139 an order under another contract?

Yes. 36C24125F0139 is a delivery order under 36F79725D0093, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24125F0139 competed?

The extent of competition for 36C24125F0139 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award